Geneos Wealth Management’s BlackRock Technology and Private Equity Term Trust BTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-6,558
Closed -$48.1K 3231
2025
Q2
$48.1K Sell
6,558
-782
-11% -$5.17K ﹤0.01% 1592
2025
Q1
$45.9K Buy
+7,340
New +$54.6K ﹤0.01% 1523
2023
Q3
Sell
-550
Closed -$4.32K 2150
2023
Q2
$4.32K Hold
550
﹤0.01% 1775
2023
Q1
$4.42K Hold
550
﹤0.01% 1760
2022
Q4
$3.75K Hold
550
﹤0.01% 1774
2022
Q3
$3K Sell
550
-2,600
-83% -$21.7K ﹤0.01% 1816
2022
Q2
$25K Buy
+3,150
New +$28.3K ﹤0.01% 1597

Other funds holding BTX

Geneos Wealth Management's BTX Position: Q3 2025 in Review

Geneos Wealth Management sold out of BlackRock Technology and Private Equity Term Trust (BTX) in Q3 2025, closing a stake of 6,558 shares — an estimated $48.1K sold.

Geneos Wealth Management first reported a position in BTX in Q2 2022 and held it in 7 quarters. The position peaked at $48.1K in Q2 2025. 91 funds tracked by Wall St. Rank hold BTX as of Q3 2025.

  • Geneos Wealth Management reported no remaining BlackRock Technology and Private Equity Term Trust position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 6,558 BlackRock Technology and Private Equity Term Trust shares in Q3 2025, an estimated $48.1K.
  • Geneos Wealth Management first reported a position in BlackRock Technology and Private Equity Term Trust in Q2 2022 and held it in 7 quarters.
  • Geneos Wealth Management's BlackRock Technology and Private Equity Term Trust position peaked at $48.1K in Q2 2025.
  • 91 funds tracked by Wall St. Rank held BlackRock Technology and Private Equity Term Trust as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.